These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. 5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma. Müther M; Koch R; Weckesser M; Sporns P; Schwindt W; Stummer W Neurosurgery; 2019 Dec; 85(6):E1020-E1029. PubMed ID: 31215632 [TBL] [Abstract][Full Text] [Related]
47. The Impact of Extensive Surgical Resection of Butterfly Glioblastomas on Outcomes in the Presence of TERT Mutation and EGFR Amplification: A Retrospective Cohort Study. Hekimoglu M; Basak AT; Akgun MY; Ozer H; Ozgen U; Maleki R; Saban D; Oktenoğlu T; Ozer AF; Sasani M Cancer Control; 2024; 31():10732748241288121. PubMed ID: 39327682 [TBL] [Abstract][Full Text] [Related]
48. FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment. Leiva-Salinas C; Schiff D; Flors L; Patrie JT; Rehm PK Radiology; 2017 May; 283(2):508-514. PubMed ID: 28234553 [TBL] [Abstract][Full Text] [Related]
49. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients. Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115 [TBL] [Abstract][Full Text] [Related]
50. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681 [TBL] [Abstract][Full Text] [Related]
51. Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study. Gerritsen JKW; Viëtor CL; Rizopoulos D; Schouten JW; Klimek M; Dirven CMF; Vincent AJE Acta Neurochir (Wien); 2019 Feb; 161(2):307-315. PubMed ID: 30617715 [TBL] [Abstract][Full Text] [Related]
56. Dissociation Between 11C-Methionine-Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Imaging in Longitudinal Features of Glioblastoma After Postoperative Radiotherapy. Kawasaki T; Miwa K; Shinoda J; Asano Y; Takei H; Ikegame Y; Yokoyama K; Yano H; Iwama T World Neurosurg; 2019 May; 125():93-100. PubMed ID: 30716494 [TBL] [Abstract][Full Text] [Related]
57. Effects of 5-ALA dose on resection of glioblastoma. Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009 [TBL] [Abstract][Full Text] [Related]
58. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843 [TBL] [Abstract][Full Text] [Related]
59. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. Butowski N; Lamborn KR; Berger MS; Prados MD; Chang SM J Neurooncol; 2007 Oct; 85(1):87-94. PubMed ID: 17457513 [TBL] [Abstract][Full Text] [Related]
60. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy. Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]